Australia, in particular the state of Victoria, is internationally recognised for its excellence in biomedical research. This provides a compelling opportunity for drug discovery and biomedical science translation.
Medtech and pharma sector strategy
Victorian Government actions since March 2016 include:
$10m contribution to the $80m BioCurate initiative, to accelerate drug development.